Liver Transplantation

Article	Citations
Issue Information ‐ Author Checklist	63
Making the best use of testing for blood phosphatidylethanol	55
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	41
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study	41
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	40
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	40
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	39
CAQ Corner: Deceased donor selection and management	37
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	37
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	37
Acute liver failure: Do we have a consensus regarding management?	37
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	36
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	35
Introducing the Certificate of Added Qualification (CAQ) Corner	34
Issue Information	33
Issue Information	32
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	30
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	28
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	28
Machine learning improves post-transplantation HCC recurrence prediction	28
Three problems, two viruses, and one man with a vision and voice: Larry Kramer, medical activist	28
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	26
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	25
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	25
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	25

Postoperative complications after liver transplantation: Are we making progress?	24
Semaglutide is effective in achieving weight loss in liver transplant recipients	24
Impact of acuity circles policy on ABO blood type–related waitlist outcomes in liver transplantation	24
Robotic liver transplantation: University of Modena experience	24
Incidence and risk factors for chronic rejection in pediatric liver transplantation	23
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	22
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	21
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	21
PRO: All patients should receive a palliative care consult during LT evaluation	21
PRO: Is the management of ACLF better in a liver-dedicated ICU?	21
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	20
Issue Information ‐ Author Checklist	20
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	20
Bariatric surgery post-liver transplantation: A Belgian nationwide study	20
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	19
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	19
Erratum	19
Liver transplantation for pediatric liver malignancies	19
When worlds collide	19
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	19
Issue Information	18
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	18
Issue Information	18
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	18
Issue Information ‐ Author Checklist	18
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	17
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	17
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	17
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	17
Operational tolerance is not always permanent	17
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	16
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	16
Twelve is the new fifteen: The evolving MELD paradigm	15
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	15
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	15
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	15
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	15
Policy Corner: HCC exception update	15
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	15
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	14
	14
Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	14
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	14
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	14
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	14
Outcomes using steatotic liver grafts: Will machines score the final goal?	13
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	13
A new tool to predict future liver allograft dysfunction?	13
Issue Information	13
Looking for literal improvement in liver transplant outcomes	12

Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	12
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	12
Issue Information	12
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	12
Navigating the road to liver transplantation equity	12
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	12
Reply: ChatGPT and unknown clinical questions about liver transplantation	12
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	12
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	12
Issue Information ‐ Instructions to Authors	12
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	11
Priority for kidney after liver transplantation: A safety net for all?	11
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	11
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	11
From gut to graft: Can microbiota shape pediatric liver transplant outcomes?	11
Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	11
Long‐term quality of life of living liver donors: A Japanese nationwide survey	11
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	11
Cannabis and liver transplant: We need to chill, man	11
Long term considerations following living liver donation – guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety	11
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	11
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	11
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	11
Decompensated cirrhosis but low MELD—Should we wait or refer for liver transplantation?	11
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	10
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	10
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	10
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	10
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	10
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	10
Issue Information	10
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	10
No Salvation Without Regeneration	9
RAPID progress: Living-donor liver transplantation for unresectable colorectal liver metastases	9
Management of portal vein thrombosis in candidates for liver transplant	9
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	9
Letter to the Editor: Few-shot learning—A methodological bridge from pilot experiments to large-scale studies in refractory ascites research	9
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease	9
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	9
Reply: Is the SRTR metric “Survival on the Waitlist” still useful in the age of machine perfusion and short liver transplant wait times?	9
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	9
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	9
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	9
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	9
Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months	9
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	9
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	9
HepB-CpG vaccination: An alternate strategy to lifelong antiviral therapy in patients transplanted for chronic hepatitis B	9
Financial burden of cirrhosis is significantly reduced after liver transplantation	8
No transplant candidate left behind	8
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	8
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	8
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Policy Corner: Polycystic liver disease MELD exception update	8
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	8
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	8
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	8
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	8
Bacterascites confers poor patient prognosis beyond MELD prediction	8
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	8
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	8
Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	7
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	7
Informatics-driven solutions for optimal care delivery in liver transplantation	7
Untangling the web of waitlist dropout in HCC	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	7
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	7
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	7
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	7
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	7
Erratum	7
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	7
Second thoughts about second opinions for liver transplantation	7
Does hepatectomy technique matter?	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Issue Information	7

The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	7
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	7
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	7
Issue Information ‐ Instructions to Authors	7
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Policy Corner: Cholangitis exception update	7
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	6
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	6
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	6
Fellows’ Corner	6
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	6
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	6
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	6
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	6
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	6
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	6
Barriers to liver transplant referral in safety net settings: A national provider survey	6
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	6
Issue Information ‐ Instructions to Authors	6
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	6
Quantitative methods for optimizing patient outcomes in liver transplantation	6
Anonymity: What does it mean and why is it important to anonymous living liver donors?	6
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	6
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	6
Portopulmonary hypertension: May we agree to disagree?	6
Reduction of hepatectomy times in Dutch organ procurement teams	6
Geospatial analysis of liver donation after death by drug intoxication	6
Maximizing outcomes by donor-recipient age matching in liver transplantation	6
Organ monitoring and identification of ischemic liver injury during ex situ porcine liver machine perfusion—A randomized controlled study	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
“Winning the peace” against obesity in recipients of liver transplant	6
Efficiency of machine perfusion in pediatric liver transplantation	5
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	5
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	5
Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation	5
Issue Information	5
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Creation of a new VA liver transplantation center increased access and retained care within the Veterans Health Administration	5
When the MELD is low, the bar is high—Gender-related disparities in early liver transplantation	5
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	5
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	5
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	5
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	5
Living donor liver transplantation in infants 6 kg or less: Impact of graft type and size on postoperative outcomes	5
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	5
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
Proposing a Framework to Assess the Methodological Quality of Prognostic Models	5
Issue Information ‐ Author Checklist	5
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	5
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	5
Long‐term follow‐up of living liver donors	5
Issue Information ‐ Author Checklist	5
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	5
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	5
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	5
Liver transplantation in well-selected patients with unresectable colorectal liver metastases	5
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	5
Rethinking the use of immunotherapy post-liver transplantation: Standardized protocols with low risk of rejection	5
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	5
A Modified liver donor risk index for pediatric liver transplant recipients	5
A scoping review of nonmedical barriers to living donor liver transplant	5
Multicenter assessment of hypertension management among liver transplantation recipients	4
Efficacy and safety of adhesion barrier in living-donor liver transplantation with right liver graft to prevent delayed gastric emptying	4
	4
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant	4
“To sleep—perchance to dream”: Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion	4
Don’t delay: Early paracentesis can save lives in hospitalized patients with cirrhosis and ascites	4
Timing is everything: sleeve gastrectomy and liver transplantation	4
Achieving Equity for Liver Transplantation Recipients With Chronic Kidney Disease	4
Less salt and more water for children—not just dietary, but transplant management too	4
Will This Liver Work? The “Ibis Redibis” of Machine Preservation Viability Assessment	4
Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high‐volume transplant center	4
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	4
Steatotic liver disease after pediatric liver transplantation	4
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant	4
Introducing the Liver Transplant Policy Corner	4
Letter to the Editor: How does ex vivo liver perfusion help improve the outcomes of liver transplantation in donation after cardiac death donors?	4
Alloantibody and crossmatch in simultaneous liver and kidney transplantation: Is the jury still out?	4
Acute cellular rejection in liver transplantation recipients following coronavirus disease 2019 vaccination	4
Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden	4
Progress and challenges in assessing allograft health in liver transplantation	4
Strategic leadership and financial governance in liver transplantation: Global insights from the International Liver Transplantation Society Congress 2025	4
	4
“Not too much, not too little, just right”—Finding the Goldilocks point in pediatric immunosuppression minimization	4
A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study	4
Policy Corner: Ischemic cholangiopathy associated with donation after cardiac death	4
Seeking Editor for Clinical Liver Disease	4
Jehovah’s Witnesses: Challenges in liver disease management and in liver transplantation	4